The goal of this activity is for learners to be better able to understand the recent data evaluating treatment strategies for patients with lung cancer and how best to integrate these data into the clinical care of patients.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org/viewarticle/1001158
- Start Date: 2024-06-13 05:00:00
- End Date: 2024-06-13 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.5 hours
- Commercial Support: Source: Eli Lilly - Amount: 9123.0 - Is Kind Support: False Source: Genentech (Any division) - Amount: 9123.0 - Is Kind Support: False Source: Janssen (Any division) - Amount: 27174.0 - Is Kind Support: False
- Activity Type: Other/Blended Learning
- CME Finder Type: Other
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest